H_CD20 KO RAMOS Cell Line
Cat. No.
GM-C45171
Size
1 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Related products
Specifications
Cat. No GM-C45171
Product H_CD20 KO RAMOS Cell Line
Description H_CD20 KO RAMOS Cell Line is a clonal stable cell line derived from RAMOS cells with a knockout of human CD20
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_CD20
Gene ID/Uniprot ID  
Host Cell RAMOS
Recovery Medium RPMI 1640+10% FBS+1% P.S
Growth medium RPMI 1640+10% FBS+1% P.S+10 μg/mL Blasticidin+0.25 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C45171
Product H_CD20 KO RAMOS Cell Line
Description H_CD20 KO RAMOS Cell Line is a clonal stable cell line derived from RAMOS cells with a knockout of human CD20
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_CD20
Gene ID/Uniprot ID  
Host Cell RAMOS
Recovery Medium RPMI 1640+10% FBS+1% P.S
Growth medium RPMI 1640+10% FBS+1% P.S+10 μg/mL Blasticidin+0.25 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_CD20 KO RAMOS Cell Line (Cat. GM-C45171) was determined by flow cytometry using Anti-CD20 mIgG2a Antibody (ocrelizumab) (Cat. GM-88845AB).
H_CD20 KO RAMOS Cell Line (Cat. GM-C45171) was determined by flow cytometry using Anti-CD20 mIgG2a Antibody (rituximab) (Cat. GM-88846AB).
Genotype Verification
The Sanger sequencing of the H_CD20 KO RAMOS Cell Line showed successful knockout of CD20.
Materials
Reagent Ordering Information
RPMI 1640 gibco/C11875500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Blasticidin Genomeditech/GM-040404
Anti-CD20 mIgG2a Antibody Genomeditech/GM-88845AB
Anti-CD20 mIgG2a Antibody Genomeditech/GM-88846AB
Reagent Ordering Information
RPMI 1640 gibco/C11875500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Blasticidin Genomeditech/GM-040404
Anti-CD20 mIgG2a Antibody Genomeditech/GM-88845AB
Anti-CD20 mIgG2a Antibody Genomeditech/GM-88846AB
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+10 μg/mL Blasticidin+0.25 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          After the first resuscitation, the cells can be subcultured after approximately 2–3 days. After 1 to 2 passages, the culture medium can be changed to a growth medium supplemented with antibiotics. If passage is not possible within 3 days, it is recommended to supplement with recovery medium as appropriate and place the flask in a horizontal position.

b)         When the cell density reaches 8E5 cells/mL, perform a 1:3 split, and continue subculturing every 2–3 days. Do not allow the cell density to exceed 1E6 cells/mL. It is recommended to use T25 flasks for passaging and culture.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 4E5 and 8E5 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          The cell line is density-sensitive; during routine culture and passaging, maintain the cell density within an appropriate range.

b)         FBS should be heat-inactivated at 56°C for 30 minutes to inactivate complement and certain viruses, with minimal impact on most growth factor and cytokine activities.

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+10 μg/mL Blasticidin+0.25 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          After the first resuscitation, the cells can be subcultured after approximately 2–3 days. After 1 to 2 passages, the culture medium can be changed to a growth medium supplemented with antibiotics. If passage is not possible within 3 days, it is recommended to supplement with recovery medium as appropriate and place the flask in a horizontal position.

b)         When the cell density reaches 8E5 cells/mL, perform a 1:3 split, and continue subculturing every 2–3 days. Do not allow the cell density to exceed 1E6 cells/mL. It is recommended to use T25 flasks for passaging and culture.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 4E5 and 8E5 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          The cell line is density-sensitive; during routine culture and passaging, maintain the cell density within an appropriate range.

b)         FBS should be heat-inactivated at 56°C for 30 minutes to inactivate complement and certain viruses, with minimal impact on most growth factor and cytokine activities.

Related products
CD20(MS4A1)
ADCC FcγRIIIa(158V) Jurkat Effector Cell Line Cynomolgus_CD20 CHO-K1 Cell line H_CD20 CHO-K1 Cell Line
H_CD20 HEK-293 Cell Line Mouse_CD20 CHO-K1 Cell Line
Anti-CD20 hIgG1 Reference Antibody Anti-CD20 hIgG1 Reference Antibody Anti-CD3×CD20 hIgG1 Bispecific Antibody 
Anti-H_MS4A1(CD20) hIgG1 Antibody    
CD19
H_CD19 KO Raji Cell Line Cynomolgus_CD19 CHO-K1 Cell Line Cynomolgus_CD19 HEK-293 Cell Line
H_CD19 CHO-K1 Cell line H_CD19 HEK-293 Cell Line Mouse_CD19 CHO-K1 Cell Line
Anti-CD19 hIgG1 Reference Antibody  Anti-CD19×CD3 hIgG1 Antibody Anti-H_CD19 hIgG1/hIgG2 Antibody
CD3
ADCC FcγRIIIa(158V) Reporter Jurkat(CD3 KO) Cell Line Jurkat CD3-BsAb Reporter Cell Line Cynomolgus_CD3 HEK-293 Cell Line
Cynomolgus_CD3E(Membrane Bound ECD) CHO-K1 Cell Line H_CD3 CHO-K1 Cell Line H_CD3 HEK-293 Cell Line
H_CD3(TCR V2) CHO-K1 Cell Line H_CD3(TCR V2) HEK-293 Cell Line H_CD3D CD3E KO Jurkat Cell Line
H_CD3E KO Jurkat Cell Line H_CD3E(Membrane Bound ECD) CHO-K1 Cell Line Mouse_CD3 HEK-293 Cell Line
Anti-CD19×CD3 hIgG1 Antibody Anti-CD3 epsilon hIgG1 Antibody  Anti-CD3 hIgG1 Antibody
Anti-CD3×CD20 hIgG1 Bispecific Antibody  Anti-CD3×FCRL5 hIgG1 Bispecific Antibody Anti-CD3E×BCMA hIgG4 Reference Antibody 
Anti-CD3E×DLL3 hIgG1 Bispecific Antibody Anti-CD3E×MUC17 hIgG1 Bispecific Antibody Anti-mouse CD3ε mIgG2a Antibody
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
H_CD20 KO RAMOS Cell Line
Cat. No.
GM-C45171
Size
1 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Related products
Specifications
Cat. No GM-C45171
Product H_CD20 KO RAMOS Cell Line
Description H_CD20 KO RAMOS Cell Line is a clonal stable cell line derived from RAMOS cells with a knockout of human CD20
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_CD20
Gene ID/Uniprot ID  
Host Cell RAMOS
Recovery Medium RPMI 1640+10% FBS+1% P.S
Growth medium RPMI 1640+10% FBS+1% P.S+10 μg/mL Blasticidin+0.25 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C45171
Product H_CD20 KO RAMOS Cell Line
Description H_CD20 KO RAMOS Cell Line is a clonal stable cell line derived from RAMOS cells with a knockout of human CD20
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_CD20
Gene ID/Uniprot ID  
Host Cell RAMOS
Recovery Medium RPMI 1640+10% FBS+1% P.S
Growth medium RPMI 1640+10% FBS+1% P.S+10 μg/mL Blasticidin+0.25 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_CD20 KO RAMOS Cell Line (Cat. GM-C45171) was determined by flow cytometry using Anti-CD20 mIgG2a Antibody (ocrelizumab) (Cat. GM-88845AB).
H_CD20 KO RAMOS Cell Line (Cat. GM-C45171) was determined by flow cytometry using Anti-CD20 mIgG2a Antibody (rituximab) (Cat. GM-88846AB).
Genotype Verification
The Sanger sequencing of the H_CD20 KO RAMOS Cell Line showed successful knockout of CD20.
Materials
Reagent Ordering Information
RPMI 1640 gibco/C11875500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Blasticidin Genomeditech/GM-040404
Anti-CD20 mIgG2a Antibody Genomeditech/GM-88845AB
Anti-CD20 mIgG2a Antibody Genomeditech/GM-88846AB
Reagent Ordering Information
RPMI 1640 gibco/C11875500BT
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Blasticidin Genomeditech/GM-040404
Anti-CD20 mIgG2a Antibody Genomeditech/GM-88845AB
Anti-CD20 mIgG2a Antibody Genomeditech/GM-88846AB
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+10 μg/mL Blasticidin+0.25 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          After the first resuscitation, the cells can be subcultured after approximately 2–3 days. After 1 to 2 passages, the culture medium can be changed to a growth medium supplemented with antibiotics. If passage is not possible within 3 days, it is recommended to supplement with recovery medium as appropriate and place the flask in a horizontal position.

b)         When the cell density reaches 8E5 cells/mL, perform a 1:3 split, and continue subculturing every 2–3 days. Do not allow the cell density to exceed 1E6 cells/mL. It is recommended to use T25 flasks for passaging and culture.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 4E5 and 8E5 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          The cell line is density-sensitive; during routine culture and passaging, maintain the cell density within an appropriate range.

b)         FBS should be heat-inactivated at 56°C for 30 minutes to inactivate complement and certain viruses, with minimal impact on most growth factor and cytokine activities.

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+10 μg/mL Blasticidin+0.25 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          After the first resuscitation, the cells can be subcultured after approximately 2–3 days. After 1 to 2 passages, the culture medium can be changed to a growth medium supplemented with antibiotics. If passage is not possible within 3 days, it is recommended to supplement with recovery medium as appropriate and place the flask in a horizontal position.

b)         When the cell density reaches 8E5 cells/mL, perform a 1:3 split, and continue subculturing every 2–3 days. Do not allow the cell density to exceed 1E6 cells/mL. It is recommended to use T25 flasks for passaging and culture.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 4E5 and 8E5 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          The cell line is density-sensitive; during routine culture and passaging, maintain the cell density within an appropriate range.

b)         FBS should be heat-inactivated at 56°C for 30 minutes to inactivate complement and certain viruses, with minimal impact on most growth factor and cytokine activities.

Related products
CD20(MS4A1)
ADCC FcγRIIIa(158V) Jurkat Effector Cell Line Cynomolgus_CD20 CHO-K1 Cell line H_CD20 CHO-K1 Cell Line
H_CD20 HEK-293 Cell Line Mouse_CD20 CHO-K1 Cell Line
Anti-CD20 hIgG1 Reference Antibody Anti-CD20 hIgG1 Reference Antibody Anti-CD3×CD20 hIgG1 Bispecific Antibody 
Anti-H_MS4A1(CD20) hIgG1 Antibody    
CD19
H_CD19 KO Raji Cell Line Cynomolgus_CD19 CHO-K1 Cell Line Cynomolgus_CD19 HEK-293 Cell Line
H_CD19 CHO-K1 Cell line H_CD19 HEK-293 Cell Line Mouse_CD19 CHO-K1 Cell Line
Anti-CD19 hIgG1 Reference Antibody  Anti-CD19×CD3 hIgG1 Antibody Anti-H_CD19 hIgG1/hIgG2 Antibody
CD3
ADCC FcγRIIIa(158V) Reporter Jurkat(CD3 KO) Cell Line Jurkat CD3-BsAb Reporter Cell Line Cynomolgus_CD3 HEK-293 Cell Line
Cynomolgus_CD3E(Membrane Bound ECD) CHO-K1 Cell Line H_CD3 CHO-K1 Cell Line H_CD3 HEK-293 Cell Line
H_CD3(TCR V2) CHO-K1 Cell Line H_CD3(TCR V2) HEK-293 Cell Line H_CD3D CD3E KO Jurkat Cell Line
H_CD3E KO Jurkat Cell Line H_CD3E(Membrane Bound ECD) CHO-K1 Cell Line Mouse_CD3 HEK-293 Cell Line
Anti-CD19×CD3 hIgG1 Antibody Anti-CD3 epsilon hIgG1 Antibody  Anti-CD3 hIgG1 Antibody
Anti-CD3×CD20 hIgG1 Bispecific Antibody  Anti-CD3×FCRL5 hIgG1 Bispecific Antibody Anti-CD3E×BCMA hIgG4 Reference Antibody 
Anti-CD3E×DLL3 hIgG1 Bispecific Antibody Anti-CD3E×MUC17 hIgG1 Bispecific Antibody Anti-mouse CD3ε mIgG2a Antibody
Message consultation
reset
submit
Message
Message consultation
reset
submit